Tweet Higgins V, Parker ML, Ahmed B, Bhayana V, Booth RA, Chen Y, Collier C, Freedman MS, Gagné M, Ismail OZ, Gifford JL, Macri J, Moore CS, Newbigging A, Olayinka L, Poliakov I, Rodriguez-Capote K, Schneider R, Thebault S, Yang L, Beriault DR. Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal…
Early effective therapy is the Answer. If not what’s the question
Tweet Alroughani R, Ahmed SF. Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational study. Mult Scler Relat Disord. 2026 Jan 19;108:107024. doi: 10.1016/j.msard.2026.107024. Epub ahead of print. Background: The evolution of high-efficacy disease-modifying therapies (HE-DMTs) has significantly shifted the management of relapsing-remitting multiple sclerosis (RRMS). Real-world evidence highlighted the…
MS patients see lasting benefits from Briumvi treatment, study says
Continued treatment with TG Therapeutics’ Briumvi (ublituximab) provides sustained clinical benefits for people with relapsing forms of multiple sclerosis (MS), particularly if started earlier. That’s according to data from the ULTIMATE I (NCT03277261) and ULTIMATE II (NCT03277248) Phase 3 clinical trials and their ongoing open-label extension (NCT04130997). After five years of follow-up, more than 80%…
Intention & Expectations
By Stacie Prada Lately, I’ve been pausing periodically throughout each day to ask myself, “How do I want to show up today?” It only takes a moment, just enough time for a brief inhale and exhale. It allows me to … Continue reading → Source: blog.mymsaa.org
Remyelination in Monkeys with Clemastine
Tweet In the UK people have a real issue with non-human primate research and there is essentially no MS related work ongoing in the UK. You know we love our furry friends and in the 1980s when I worked in a place where people worked on marmosets and Epstein Barr Virus, they used to have…
It may not always look like it, but I’m not giving up
Several (OK, many) years ago, I was having lunch with a group of fellow Green Berets when a news story appeared on the TV. The report covered a recent tragedy, and during an interview with a survivor, it was mentioned that one of the victims had not survived because they had “given up.” This sparked…
UCSF, Nektar team to test potential of antibody therapy for MS
The University of California San Francisco (UCSF) is teaming up with Nektar Therapeutics to study the potential of NKTR-0165, an experimental antibody that activates the tumor necrosis factor receptor type 2 (TNFR2), to treat multiple sclerosis (MS). UCSF neurologist Stephen L. Hauser, MD, and his postdoctoral researcher Chaitrali Saha, PhD, will lead the project. The…
Breastfeeding as a baby could slow MS progression later in life
Breastfeeding for longer during infancy may delay the onset of multiple sclerosis (MS) and slow its progression for people who later develop the disease, according to a study from Turkey. Researchers found that adults with MS who had been breastfed for more than six months had less severe disease than those who had been breastfed…
Cost of Drugs
Tweet Hartung DM et al. Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 202116 e200597 Neurol Clin Practise 2026 https://doi.org/10.1212/CPJ.00000000002005 This is a paper that tweaked my interest and says to the people in the UK to spare a thought for those in the US and their drug costs. No wonder…
Pharma funds to Neuros and others..No wonder they cost so much
Tweet You wanted it you got it the hottest band in the World….Piss I meant you wanted it you got…..Neurologists feeding from the Pharma trough. You may have noted that the costs of MS drugs in the USA, are particularly high. Well if you want your want to know where your money is going? Some…